主动脉瘤腔内修复术后早期和晚期心血管事件高风险
这项全国性回顾性登记研究纳入2000至2018年因破裂或未破裂胸/腹主动脉瘤行腔内修复的8641例患者,分析主要不良心血管事件(MACE)。结果显示破裂动脉瘤修复后90天MACE发生率显著高于未破裂者,女性及年龄、心绞痛、心衰、卒中病史与MACE相关,长期EVAR与TEVAR间无差异。
要点
- 破裂性TAA行TEVAR后90天MACE为26.7%,未破裂iTAA为10.2%(HR 3.02)。
- 破裂性AAA行EVAR后90天MACE为26.9%,未破裂iAAA为3.7%(HR 8.5)。
- 女性未破裂和破裂腔内修复后长期MACE风险均较高(HR 1.14和1.36)。
核心结论
- 这项全国性队列研究仍显示主动脉腔内修复术后早期和晚期心血管事件风险高,可能需要全面的术后心血管疾病预防策略。
研究设计与样本
- 全国性回顾性登记研究,纳入2000至2018年因未破裂或破裂胸/腹主动脉瘤行腔内修复的患者,共8641例;TEVAR 634例(iTAA 488例,rTAA 146例),EVAR 8007例(iAAA 7071例,rAAA 936例)。
主要发现
- iTAA行TEVAR后90天MACE发生率为10.2%,rTAA为26.7%(HR 3.02,95%CI 1.99-4.6)。
- iAAA行EVAR后90天MACE发生率为3.7%,rAAA为26.9%(HR 8.5,95%CI 7.16-10.11)。
- iTAA行TEVAR后90天MACE累积发生率高于iAAA行EVAR(HR 2.82,95%CI 2.09-3.82),但破裂动脉瘤修复后两种术式间无差异。
- 中位随访3.28年(IQR 1.31-5.94);破裂或未破裂动脉瘤修复后,EVAR与TEVAR长期MACE无差异:破裂90天-5年HR 1.14(95%CI 0.76-1.71),5-10年HR 0.78(95%CI 0.31-1.96);未破裂90天-5年HR 1.19(95%CI 0.97-1.46),5-10年HR 0.82(95%CI 0.56-1.21)。
- 女性未破裂(HR 1.14,95%CI 1.03-1.27)和破裂(HR 1.36,95%CI 1.12-1.65)腔内修复后长期MACE发生率较高;未破裂修复后,年龄(HR 1.05,95%CI 1.04-1.05)、心绞痛病史(HR 1.19,95%CI 1.08-1.32)、心力衰竭(HR 1.90,95%CI 1.69-2.13)和卒中(HR 1.33,95%CI 1.15-1.53)与MACE相关。
临床怎么用
- 作者认为可能需要全面的术后心血管疾病预防策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of this population-based study was to analyze short- and long-term major adverse cardiovascular events (MACE) after endovascular repair of ruptured or nonruptured thoracic (TAA) and abdominal aortic aneurysms (AAA). METHODS: Nationwide retrospective registry study including all patients who underwent endovascular repair (thoracic endovascular aortic repair, TEVAR; abdominal endovascular aneurysm repair, EVAR) for nonruptured/intact (iAAA/iTAA) or ruptured (rAAA/rTAA) abdominal or thoracic aneurysms between 2000 and 2018. The primary outcome was a composite of cardiovascular death, stroke, or myocardial infarction (MACE). RESULTS: There were 8,641 patients with TAA and AAA; 634 TEVAR procedures [iTAA 488; rTAA 146], and 8007 EVAR procedures [iAAA 7071; rAAA 936] were performed. MACE incidence at 90-day after TEVAR for iTAA was 10.2% and for rTAA 26.7% [HR 3.02, 95% CI 1.99-4.6]; MACE at 90-day after EVAR for iAAA was 3.7% and for rAAA 26.9% [HR 8.5, 95% CI: 7.16-10.11]. There was a higher cumulative incidence of MACE at 90-day after TEVAR for iTAA compared to EVAR for iAAA [HR 2.82, 95% CI 2.09-3.82] but no difference between the procedures after ruptured aneurysm repair. The median follow-up time was 3.28 years [IQR 1.31-5.94]. There was no long-term difference in MACE between EVAR and TEVAR after ruptured [90 days-5 years: HR 1.14, 95% CI 0.76-1.71; 5-10 years: HR 0.78, 95% CI 0.31-1.96] or intact [90 days-5 years: HR 1.19, 95% CI 0.97-1.46; 5-10 years: HR 0.82, 95% CI 0.56-1.21] aneurysm repair. Female gender had higher long-term incidence of MACE after intact [HR 1.14, 95% CI 1.03-1.27] and ruptured [HR 1.36, 95% CI 1.12-1.65] endovascular aortic aneurysm treatment. After intact aneurysms repair; age [HR 1.05, 95% CI 1.04-1.05], history of angina pectoris [HR 1.19, 95% CI 1.08-1.32], heart failure [HR 1.90, 95% CI 1.69-2.13], and stroke [HR 1.33, 95% CI 1.15-1.53] were associated with MACE. CONCLUSIONS: This nationwide cohort study still demonstrated a high risk of early and late cardiovascular events after endovascular aortic repair. Comprehensive strategies for postoperative cardiovascular disease prevention may be needed here.
引用
- Hammo S, Grannas D, Wahlgren CM, et al. High Risk of Early and Late Cardiovascular Events After Endovascular Aortic Aneurysm Repair. Ann Vasc Surg. 2022. PMID: 35483617. doi:10.1016/j.avsg.2022.04.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。